Study on the Efficacy of Long-term Drainage of Subdural Effusion After Decompressive Craniectomy
A Randomised Controlled Trial to Evaluate Long-term Drainage for Patients Undergoing Decompressive Craniectomy With the Complication of Subdural Diffusion
1 other identifier
interventional
160
1 country
1
Brief Summary
Drilling or puncture drainage is commonly used in TBI patients with subdural effusion following decompressive craniectomy who fail to respond to conservative treatment, but there is no exact regulation or guideline recommendation for the drainage time. The investigators aimed to conduct a randomized controlled trial to evaluate the efficacy and safety of long-term versus short-term drainage in the treatment of subdural effusion after decompressive craniectomy in patients with traumatic brain injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2024
CompletedFirst Posted
Study publicly available on registry
April 30, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
May 6, 2024
May 1, 2024
2 years
April 25, 2024
May 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Recurrence rate of subdural effusion 1 month after drainage catheter removal.
The evaluation criteria of whether the effusion has recurred is based on the diagnostic results of the imaging examination. The specific manifestations are that the skull CT examination finds that the effusion has reappeared in the original effusion area.
1 month after drainage catheter removal.
Secondary Outcomes (4)
Incidence of related complications.
1 month after drainage catheter removal.
Method of re-intervention after recurrence of effusion.
1 month after drainage catheter removal.
Length of stay in hospital and detailed economic evaluation.
1 month after drainage catheter removal.
GOSE (extended Glasgow Outcome Scale) scores.
1, 3 and 6 months after drainage catheter removal.
Study Arms (2)
Long-term Drainage
EXPERIMENTALThe drainage catheter is indwelling continuously and keeps to drainage for 7 days.
Short-term Drainage
ACTIVE COMPARATORThe drainage catheter is indwelling continuously and keeps to drainage for 2 days.
Interventions
After drilling or puncture, the drainage catheter is indwelling continuously and keeps to drainage for 7 days. Keep incision sterility, record the daily fluid drainage flow, and perform biochemical and bacterial culture identification tests for CSF regularly. Removing drainage catheter when the allocated time is reached. If there is still unabsorbed effusion after the allocated time is reached, the catheter placement time is extended and the relevant information is recorded.
After drilling or puncture, the drainage catheter is indwelling continuously and keeps to drainage for 2 days. Keep incision sterility, record the daily fluid drainage flow, and perform biochemical and bacterial culture identification tests for CSF regularly. Removing drainage catheter when the allocated time is reached. If there is still unabsorbed effusion after the allocated time is reached, the catheter placement time is extended and the relevant information is recorded.
Eligibility Criteria
You may qualify if:
- Unilateral DC surgery was performed on TBI patients after injury;
- Subdural effusion occurred for the first time and occurred within 30 days after DC surgery;
- Unilateral effusion accumulation (can appear on the same or opposite side of the bone flap);
- The subdural effusion cannot be absorbed or has no decreasing trend with conservative treatment and consistent with the indications for surgical treatment;
- Sign the study informed consent;
You may not qualify if:
- History of craniocerebral disease or craniocerebral surgery;
- Combined with ventricular hydrocephalus;
- Other factors lead to poor prognosis or affect the treatment plan of the patient, even if the effusion can be recovered well, but severe pre-existing disability or severe co-morbidity such as serious heart disease leads to poor prognosis or even death;
- Pregnant female.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RenJi Hospitallead
- Zhujiang Hospitalcollaborator
- Clinical Research Institute, Shanghai Jiao Tong University School of Medicinecollaborator
Study Sites (1)
Brain Injury Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, 201114, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jiyao Jiang, Dr.
Renji Hospital,School of Medicine,Shanghai Jiao Tong University
- STUDY DIRECTOR
Junfeng Feng, Dr.
Renji Hospital,School of Medicine,Shanghai Jiao Tong University
- STUDY DIRECTOR
Qinghua Wang, Dr.
Southern Medical University, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2024
First Posted
April 30, 2024
Study Start
June 1, 2024
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
May 6, 2024
Record last verified: 2024-05